Journal of Alzheimer's Research and Therapy

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Alzheimer's  Research and Therapy-His current research thrust is to high-throughput screen and design-Xudong Huang

United States

Co-Director, Neurochemistry Lab, Psychiatry Department, Massachusetts General Hospital and Harvard Medical School

617-724-9778

Send an Email

Xudong Huang

Address:

Neurochemistry Laboratory, MGH Psychiatry, 149 13th Street, Charlestown, MA 02129, USA

Research Interests:

His current research thrust is to high-throughput screen and design, synthesize, and characterize targeted theranostic compounds for human diseases such as Alzheimer’s disease, cancer, and cardiovascular diseases, etc. In addition, his lab is exploring novel applications of biomedical informatics (such as medical image analysis and bioinformatics) and cheminformatics (such as structure-based rational drug design and in-silico drug screening) in systems biology and nanotechnology in translational medicine.

Biography:

  • Dr. Xudong Huang is an assistant professor of Harvard Medical School (HMS), and the Co-director for Neurochemistry Lab at Psychiatry Department of Massachusetts General Hospital (MGH).
  • Dr. Huang received his PhD from MIT (Nuclear Science and Engineering). He performed his postdoctoral work at Massachusetts General Hospital MGH/HMS.
  • His current research thrust is to high-throughput screen and design, synthesize, and characterize targeted theranostic compounds for human diseases such as Alzheimer’s disease, cancer, and cardiovascular diseases, etc.
  • In addition, his lab is exploring novel applications of biomedical informatics (such as medical image analysis and bioinformatics) and cheminformatics (such as structure-based rational drug design and in-silico drug screening) in systems biology and nanotechnology in translational medicine.
  • Dr. Huang serves on scientific advisory and editorial boards for several research foundations and many scientific journals.